Author

Abdul A. Shaik

Texas Tech UniversityORCID 0009-0003-7269-075XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Abdul Naji HamoodiD· 1 shared Bruce E. BloughiD· 1 shared Elliott PauliiD· 1 shared Jeremy D. BailooiD· 1 shared Jeremy Garza· 1 shared Jordan Sanchez· 1 shared Kushal Gupta· 1 shared Monica Aguilera· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Abdul Naji HamoodORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular mechanisms of 10-Butyl Ether Minocycline (BEM), a novel non-antibiotic tetracycline, as a potential treatment for inflammatory and neuroimmune-related disorders.

Abdul A. Shaik, Praneetha Panthagani, Xiaobo Liu, Stephany Navarro, Jeremy Garza, Monica Aguilera, Jordan Sanchez, Kushal Gupta, Abdul Naji Hamood, Ted Warren Reid, Bruce E. Blough, Elliott Pauli, Jeremy D. Bailoo, Susan E. Bergeson

This paper investigates the molecular mechanisms of BEM, a non-antibiotic minocycline derivative, showing it retains therapeutic pleiotropy while losing antimicrobial activity, making it a potential treatment for neuroimmune and inflammatory disorders.

bioRxiv · Jun 23, 2025 · PreprintPharmacology & Toxicology